C vs TMO · P/E 16, rev $85.22B vs P/E 24, rev $44.56B
Citigroup Inc. (C) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
C currently screens at market cap $214.73B and trailing P/E 15.5. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the C and TMO stock pages for the full models.
Not investment advice.